Lifetime cumulative incidence of CRC between 25 and 75 years of age is 48–57 per cent for MLH1, 47–51 per cent for MSH2, 18–20 per cent for MSH6, and 10 per cent for PMS2 depending on gender25. Here, PMS2 is linked to colorectal carcinoma.